Clinical Trial

Evaluating the Efficacy of NeoThelium FT in the Treatment of Pressure Injuries

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized controlled trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating pressure injuries.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-04-08; most recent amendment 2026-04-06.
Trial Details
NCT Number NCT06918548
Lead Sponsor NuScience Medical Biologics, LLC
Collaborators: SygNola, LLC
Conditions Pressure Injury
Enrollment 148 participants
Start Date 2026-07-01
Primary Completion 2028-03-01 (estimated)
Study Completion 2028-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-07